iZafe Group AB (FRA:M02) Other Financing: €0.00 Mil (TTM As of Mar. 2026)


FRA:M02 iZafe Group AB FRA:M02
48 GF Score
Price €0.03
GF Value €0.04
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is iZafe Group AB Other Financing?

iZafe Group AB FRA:M02 -5.06% 48 Other Financing is €0.00 Mil as of Mar. 2026. GuruFocus rates FRA:M02 with a GF Score™ of 48/100 and a GF Value™ of €0.04 (Modestly Undervalued). The stock has 2 warning signs investors should review.

iZafe Group AB's Other Financing for the three months ended in Mar. 2026 was €0.00 Mil.

iZafe Group AB's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was €0.00 Mil.

iZafe Group AB Other Financing Historical Data

* Premium members only.

The historical data trend for iZafe Group AB's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

iZafe Group AB Other Financing Chart

iZafe Group AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.94 0.73 1.66 0.42 1.70

iZafe Group AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:M02
48GF Score
iZafe Group AB FRA:M02
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

iZafe Group AB Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of €0.00 Mil mean?
iZafe Group AB (FRA:M02) has a Other Financing of €0.00 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for iZafe Group AB and its competitors.
Is iZafe Group AB's Other Financing too high?
iZafe Group AB's current Other Financing is €0.00 Mil. Overall, iZafe Group AB has a GF Score™ of 48/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does iZafe Group AB's Other Financing compare to ISRG and BDX?
iZafe Group AB's Other Financing of €0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Medical Devices & Instruments company?
A good Other Financing depends on the Medical Devices & Instruments industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for iZafe Group AB and its competitors. iZafe Group AB's current Other Financing is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iZafe Group AB stock overvalued right now?
Based on GuruFocus' analysis, iZafe Group AB (FRA:M02) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.04, compared to a current price of €0.03 — trading 15.5% below its estimated fair value. The current Other Financing is €0.00 Mil. iZafe Group AB's overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For iZafe Group AB (FRA:M02), the current Other Financing is €0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is iZafe Group AB (FRA:M02) Overvalued in 2026?

Based on GuruFocus' analysis, iZafe Group AB stock appears to be undervalued. The current stock price of €0.03 is trading 15.5% below its estimated GF Value™ of €0.04. GuruFocus considers iZafe Group AB to be Modestly Undervalued.

Key valuation signals for FRA:M02:

  • Other Financing: €0.00 Mil
  • GF Value™: €0.04 vs. price of €0.03 (15.5% below fair value)
  • GF Score™: 48/100 with 2 warning signs

No single metric tells the full story. See the FRA:M02 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

iZafe Group AB Business Description

Other Exchanges IZAFE B:Sweden
Address David Bagares Gata 3, Stockholm, SWE, 111 38
iZafe Group AB is a Developer of a digital medication dispensing system designed to enhance patient safety and reduce medication errors in home healthcare. The company offers a smart medication robot with automated dispensing and remote monitoring, enabling public and private healthcare providers in Sweden, the Nordics, and international markets, improved treatment adherence and reduced caregiver workload.
48GF Score

Get the complete analysis for FRA:M02

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.03
Price
€0.04
GF Value